Sort
16,300 grants matching “fatty liver disease”
The Development of Tabletop Brain-Mapping Platform
$353,769Yan Seng Elijah Yew · Tissuevision, Inc. · R43 · FY2022 · EB
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$353,762Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2019 · CA
Structure and Function of Enzymes in Fatty Acid Oxidation
$353,739Jung Ja P. Kim · Medical College Of Wisconsin · R01 · FY2010 · GM
Age, Exercise, Diet: Effects on Insulin Resistance
$353,659John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · AG
Calorie restriction and aging
$353,620Rafael De Cabo · National Institute On Aging · ZIA · FY2013 · AG
Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology
$353,583Tiangang Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
TREAT-VCU
$353,563Arun J Sanyal · Virginia Commonwealth University · U01 · FY2012 · AA
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intolerance
$353,533Miguel Angel Lanaspa Garcia · University Of Colorado Denver · R01 · FY2019 · DK
SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease
$353,529David D Moore · Baylor College Of Medicine · P01 · FY2012 · DK
SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease
$353,529David D Moore · Baylor College Of Medicine · P01 · FY2014 · DK
SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease
$353,529David D Moore · Baylor College Of Medicine · P01 · FY2016 · DK
SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease
$353,529David D Moore · Baylor College Of Medicine · P01 · FY2015 · DK
New Approaches to the Evaluation and Treatment of Acromegaly
$353,463Pamela U Freda · Columbia University Health Sciences · R01 · FY2012 · DK
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
$353,438Rajat Singh · University Of California Los Angeles · R01 · FY2023 · DK
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease
$353,403Leila Gobejishvili · University Of Louisville · R01 · FY2023 · AA
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease
$353,403Leila Gobejishvili · University Of Louisville · R01 · FY2024 · AA
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease
$353,403Leila Gobejishvili · University Of Louisville · R01 · FY2025 · AA
Liver Disease in Obesity
$353,396Anna Mae Elizabeth Diehl · Duke University · R01 · FY2006 · DK
Clinical Research Network in Nonalcoholic Steatohepatitis
$353,363Kris Kowdley · Swedish Medical Center, First Hill · U01 · FY2019 · DK
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intolerance
$353,357Miguel Angel Lanaspa Garcia · University Of Colorado Denver · R01 · FY2017 · DK
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis
$353,332Robert G Lowery · Bellbrook Labs, Llc · R43 · FY2016 · AA
High throughput screens for fatty acid uptake inhibitors
$353,323Concetta C. Dirusso · Ordway Research Institute, Inc. · R01 · FY2007 · DK
Molecular Mechanisms Underlying Macular Degenerations
$353,287Radha Ayyagari · University Of California, San Diego · R01 · FY2008 · EY
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$353,253Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2021 · DK
Elucidating dietary fructose and alcohol interactions during liver cancer development
$353,250Cholsoon Jang · University Of California-Irvine · R01 · FY2023 · AA